Company Filing History:
Years Active: 2019-2020
Title: The Innovative Contributions of Andrew Newman
Introduction
Andrew Newman is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents, Newman has focused on advancing medical treatments that target immune dysfunction.
Latest Patents
Newman's latest patents include groundbreaking work on anti-PD-1 antibodies. These antibodies are designed to inhibit the binding of PD-L1 and PD-L2 to human PD-1, thereby modulating the immune system. This innovation has potential applications in treating various immune dysfunctional disorders, including cancers. Another notable patent involves compounds that modulate the activity of CRAC channels. This patent describes methods for creating these compounds, as well as pharmaceutical compositions and medicaments that utilize them for treating conditions associated with CRAC channel activity.
Career Highlights
Throughout his career, Andrew Newman has worked with several notable companies, including BPS Bioscience, Inc. and Vivreon Biosciences, LLC. His work in these organizations has contributed to the advancement of biopharmaceuticals and therapeutic solutions.
Collaborations
Newman has collaborated with talented individuals in his field, including Xiaohui Yuan and Aaron Snead. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Andrew Newman is a key figure in the biotechnology sector, with a focus on innovative solutions for immune dysfunction. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.